HIV drug combo for early Alzheimer's disease
Part of Brain & nervous system, Mental health clinical trials.
This study tests whether a combination of two HIV medications, which may target certain genetic elements in the brain, can slow or improve memory and thinking problems in people with early Alzheimer's disease. If you have mild cognitive impairment or mild dementia due to Alzheimer's, this trial might offer a new way to help.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with mild cognitive impairment or mild Alzheimer's dementia.
- A blood test shows signs of Alzheimer's disease (p-tau217).
- Your memory problems are confirmed by a standard memory test.
- You have a study partner (like a family member or friend) who knows you well and can join visits.
- You are willing to take the study medication and attend all study visits in English.
- You are generally healthy and do not have other major brain or medical conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine, VHB937, in people with early Alzheimer's (mild cognitive impairment or mild dementia). The goal is to see if it can slow down memory loss and thinking problems.
This trial tests an investigational injection for people in the early stages of Alzheimer's. It aims to see if the drug can safely slow down memory loss and brain changes.
This study tests a drug called dimethyl fumarate to see if it can help people with early Alzheimer's disease. It may slow down memory loss and thinking problems.
This study tests an experimental drug called RO7568282 for people in the early stages of Alzheimer's disease. The goal is to see if it is safe and whether it can slow down memory loss and thinking problems.
This trial tests a vaccine that may help the immune system clear a protein linked to Alzheimer's disease. It is for people who do not have memory problems yet but have signs of the disease in their blood or brain scans.
This study tests whether a daily pill (tadalafil, a type of medicine usually used for blood pressure or erectile dysfunction) can help people with early Alzheimer's or mild memory problems. It aims to see if this drug can improve memory and slow down the disease, with the help of regular checkups and brain scans.
Hear when a new Alzheimer’s disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.